Showing results (111-120 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|December 10, 2002
The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitationsMarcella Faria, Henning UlrichCurrent Cancer Drug Targets|October 25, 2016
Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug TargetsHimanshi Kapoor, Nalini Yadav, Madhu Chopra, et al.Current Cancer Drug Targets|December 21, 2016
Virus, Oncolytic Virus and Human Prostate CancerGuang Bin Liu, Liang Zhao, Lifang Zhang, et al.Current Cancer Drug Targets|December 21, 2016
Molecular Approaches Target to Immunotherapy for HPV-Associated CancersLifang Zhang, Fang Zhou, Kong-Nan ZhaoCurrent Cancer Drug Targets|December 21, 2016
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapyHeena Singla, Sourav Kalra, Preeti Kheterpal, et al.Current Cancer Drug Targets|December 2, 2016
Identification of Novel Agents for the Treatment of Brain Metastases of Breast CancerVinay K Venishetty, Werner J Geldenhuys, Tori B Terell-Hall, et al.Current Cancer Drug Targets|September 29, 2016
Role of Oxidative Stress in Hepatitis C Virus Induced Hepatocellular CarcinomaNa Fu, Hui Yao, Yuemin Nan, et al.Current Cancer Drug Targets|February 22, 2008
The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitorsCraig W Lindsley, Stanley F Barnett, Mark E Layton, et al.Current Cancer Drug Targets|February 22, 2008
AKT signaling in regulating angiogenesisBing-Hua Jiang, Ling-Zhi LiuCurrent Cancer Drug Targets|February 22, 2008
Inhibitors of cyclin dependent kinases: useful targets for cancer treatmentP Sapra Sharma, R Sharma, R TyagiPageof 187